BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19416919)

  • 1. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis.
    Belin P; Le Du MH; Fielding A; Lequin O; Jacquet M; Charbonnier JB; Lecoq A; Thai R; Courçon M; Masson C; Dugave C; Genet R; Pernodet JL; Gondry M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7426-31. PubMed ID: 19416919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures.
    Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P
    J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from
    Dornevil K; Davis I; Fielding AJ; Terrell JR; Ma L; Liu A
    J Biol Chem; 2017 Aug; 292(33):13645-13657. PubMed ID: 28667013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature.
    Fielding AJ; Dornevil K; Ma L; Davis I; Liu A
    J Am Chem Soc; 2017 Dec; 139(48):17484-17499. PubMed ID: 29090577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationships of
    Rajput S; McLean KJ; Poddar H; Selvam IR; Nagalingam G; Triccas JA; Levy CW; Munro AW; Hutton CA
    J Med Chem; 2019 Nov; 62(21):9792-9805. PubMed ID: 31618032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-Assisted Hydroxylation and
    Nguyen RC; Yang Y; Wang Y; Davis I; Liu A
    ACS Catal; 2020 Jan; 10(2):1628-1639. PubMed ID: 32391185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450.
    Leys D; Mowat CG; McLean KJ; Richmond A; Chapman SK; Walkinshaw MD; Munro AW
    J Biol Chem; 2003 Feb; 278(7):5141-7. PubMed ID: 12435731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Structural Observation of a Substrate- and Peroxide-Bound High-Spin Ferric-Hydroperoxo Intermediate in the P450 Enzyme CYP121.
    Nguyen RC; Davis I; Dasgupta M; Wang Y; Simon PS; Butryn A; Makita H; Bogacz I; Dornevil K; Aller P; Bhowmick A; Chatterjee R; Kim IS; Zhou T; Mendez D; Paley DW; Fuller F; Alonso Mori R; Batyuk A; Sauter NK; Brewster AS; Orville AM; Yachandra VK; Yano J; Kern JF; Liu A
    J Am Chem Soc; 2023 Nov; 145(46):25120-25133. PubMed ID: 37939223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.
    Seward HE; Roujeinikova A; McLean KJ; Munro AW; Leys D
    J Biol Chem; 2006 Dec; 281(51):39437-43. PubMed ID: 17028183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.
    McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW
    J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics.
    El-Wahab HAAA; Accietto M; Marino LB; McLean KJ; Levy CW; Abdel-Rahman HM; El-Gendy MA; Munro AW; Aboraia AS; Simons C
    Bioorg Med Chem; 2018 Jan; 26(1):161-176. PubMed ID: 29183661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
    Kishk SM; McLean KJ; Sood S; Helal MA; Gomaa MS; Salama I; Mostafa SM; de Carvalho LPS; Munro AW; Simons C
    Bioorg Med Chem; 2019 Apr; 27(8):1546-1561. PubMed ID: 30837169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.
    Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C
    ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QM/MM study of the C-C coupling reaction mechanism of CYP121, an essential cytochrome p450 of Mycobacterium tuberculosis.
    Dumas VG; Defelipe LA; Petruk AA; Turjanski AG; Marti MA
    Proteins; 2014 Jun; 82(6):1004-21. PubMed ID: 24356896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis.
    McLean KJ; Cheesman MR; Rivers SL; Richmond A; Leys D; Chapman SK; Reid GA; Price NC; Kelly SM; Clarkson J; Smith WE; Munro AW
    J Inorg Biochem; 2002 Sep; 91(4):527-41. PubMed ID: 12237220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid P450 heme iron reduction by laser photoexcitation of Mycobacterium tuberculosis CYP121 and CYP51B1. Analysis of CO complexation reactions and reversibility of the P450/P420 equilibrium.
    Dunford AJ; McLean KJ; Sabri M; Seward HE; Heyes DJ; Scrutton NS; Munro AW
    J Biol Chem; 2007 Aug; 282(34):24816-24. PubMed ID: 17553785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Function Analysis of the Essential
    Padayachee T; Lamb DC; Nelson DR; Syed K
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions.
    Duffell KM; Hudson SA; McLean KJ; Munro AW; Abell C; Matak-Vinković D
    Anal Chem; 2013 Jun; 85(12):5707-14. PubMed ID: 23675886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
    Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
    ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.